Quote:

---

iam pretty sure Daiichi Sankyo parent of american western would want to distribute leronlimab around the globe .imo

---

That's a good point, and maybe that could work for COVID.

However, I'm not sure Daiichi Sankyo would have the marketing sale force necessary to promote, sell, and distribute leronolimab for the Combo HIV indication (followed, of course, by Mono).

Given the options, I would think an international sales and distribution deal with a Big Pharma would offer more advantages, and a consolidation of the entire supply chain under one banner. But that's an uneducated assumption on my part.